You can send your questions in early by heading to Slido.com now, event code #741105 |
The Alan Turing Institute and Roche have recently launched a new programme which will establish a world-leading industry and academic partnership in advanced analytics focused on enabling the transformative benefits of personalized healthcare to become a reality for patients around the world.
This strategic partnership will cover multiple activities, with the “North Star” of developing new data science methods to investigate large, complex, clinical and healthcare datasets to better understand how and why patients respond differently to treatment, and how treatment can be improved. Understanding such “treatment heterogeneity” is a problem at the forefront of modern medicine and is an essential first step toward the ambitious goal of developing a personalised approach to medical care.
To address this challenge, the partnership will make use of cutting edge datasets such as the Flatiron Health-Foundation Medicine Clinico-Genomic Database (CGDB), which links detailed, curated, electronic health records with comprehensive genomic profiling data of over 300 cancer related genes for over 60,000 oncology patients.
The purpose of this event is to introduce the Turing-Roche partnership and explain how researchers can get involved. Further details of the partnership can be seen here: The Alan Turing Institute – Roche strategic partnership | The Alan Turing Institute For any questions, please contact healthprogramme@turing.ac.uk
Follow us on Twitter @turinginst and join the conversation. |